Cytomx Therapeutics
Clinical trials sponsored by Cytomx Therapeutics, explained in plain language.
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early study tests a new drug called CX-801, alone or with pembrolizumab, in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. About 121 people will take part.
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for advanced cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug, CX-2051, in adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety and how well it works, both alone and with another drug called bevacizumab. About 160 participants will take part in t…
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC